FONDATION CARDIOMETABOLISME NUTRITION
- Country
- France
- Type
- Beneficiary
- Website
- www.ican-institute.org
- Grants received
- 12
Funding record
- 12 grants on record
- €4,494,396.90 awarded in total
- 2014–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
4 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- MEDIZINISCHE UNIVERSITAET WIEN
- NORDIC BIOSCIENCE A/S
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- ASTRAZENECA AB
- ECHOSENS
- FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Calls from this organisation
No published calls from this organisation.
Grants received
- A Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy
- Investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease
- AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients
- GRIP on MASH: Global Research Initiative for Patient Screening on MASH
- Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families.
- Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation
- Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation
- EU Patient- cEntric clinicAl tRial pLatform
- Liver Investigation: Testing Marker Utility in Steatohepatitis
- Elucidating Pathways of Steatohepatitis
- Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections
- Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.